Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Ocul Surf. 2020 Oct;18(4):713-717. doi: 10.1016/j.jtos.2020.07.005. Epub 2020 Aug 7.
To evaluate outcomes of Boston keratoprosthesis (KPro) repair versus repeat KPro as treatment for corneal melt in KPro patients.
Retrospective study of adult KPro patients with melt managed by KPro repair or repeat KPro by one surgeon (MH-D). Incidence of sight- or globe-threatening complications, risk of recurrence of melt and change in BCVA before and 3 months after the procedure were compared between both treatment groups. Change from pre-melt BCVA to final BCVA was compared between primary versus secondary repeat KPro after repair attempt.
This study included 19 eyes of 19 patients with melt and mean follow-up of 8.7 years. Primary repeat KPro was performed in 6 eyes (32%) and KPro repair in 13 eyes (68%). There were no significant differences in gender, age, or incidence of complications after KPro repair versus after repeat KPro (92% and 83% complication rate respectively, p > 0.05). The odds ratio for melt recurrence after KPro repair versus repeat KPro was 24 (95% CI 1.68-340). Change in BCVA was not significantly different in KPro repair versus repeat KPro nor in primary versus secondary repeat KPro (p > 0.05).
Repeat KPro offers a lower risk of recurrence of melt compared to KPro repair. However, repair may be considered when timely access to a new KPro and corneal graft is not possible. Delaying repeat KPro does not significantly affect final BCVA. Finally, repeat KPro is the only effective treatment when melt has led to extrusion or uncontrollable infection.
评估波士顿角膜角膜移植术(KPro)修复与重复 KPro 治疗 KPro 患者角膜溶解的结果。
对一位外科医生(MH-D)管理的 KPro 患者因角膜溶解而行 KPro 修复或重复 KPro 的成人患者进行回顾性研究。比较两组治疗方法的视力或眼球威胁性并发症发生率、角膜溶解复发风险以及手术前后 BCVA 的变化。比较修复后行初次或再次重复 KPro 后原发性与继发性重复 KPro 的术前 BCVA 与最终 BCVA 的变化。
本研究包括 19 例 19 只眼的角膜溶解患者,平均随访 8.7 年。初次重复 KPro 行 6 只眼(32%),KPro 修复行 13 只眼(68%)。KPro 修复后与重复 KPro 后性别、年龄或并发症发生率无显著差异(分别为 92%和 83%的并发症发生率,p>0.05)。KPro 修复后与重复 KPro 后角膜溶解复发的比值比为 24(95%CI 1.68-340)。KPro 修复与重复 KPro 之间以及初次与再次重复 KPro 之间的 BCVA 变化无显著差异(p>0.05)。
与 KPro 修复相比,重复 KPro 能降低角膜溶解复发的风险。然而,在无法及时获得新的 KPro 和角膜移植的情况下,可考虑修复。延迟重复 KPro 不会显著影响最终 BCVA。最后,当角膜溶解导致挤出或不可控制的感染时,重复 KPro 是唯一有效的治疗方法。